Framework agreement for somatropin medicine

Summary

Amgros I/S is procuring a non-exclusive framework agreement for injectable somatropin (ATC H01AC01), with a stated strength range of 0.1–2.5 mg. The lot covers an estimated 1,714 units for supply to Amgros, Danish hospitals and hospital pharmacies; actual demand may differ, and there is no purchase obligation. The ordinary purchasing period is 1 August 2027 to 31 July 2028, with options for delivery before or after that period and up to four extensions of up to six months each.